TrovaGene Inc (TROV)

4.43
0.05 1.10
NASDAQ : Health Care
Prev Close 4.48
Open 4.48
Day Low/High 4.46 / 4.59
52 Wk Low/High 2.85 / 9.52
Volume 30.95K
Avg Volume 281.60K
Exchange NASDAQ
Shares Outstanding 30.15M
Market Cap 139.58M
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Trovagene, Inc. - TROV

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Trovagene, Inc. - TROV

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Trovagene, Inc.

Short Interest Jumps 17.6% For TROV

Short Interest Jumps 17.6% For TROV

The most recent short interest data has been released by the NASDAQ for the 02/12/2016 settlement date, which shows a 697,508 share increase in total short interest for TrovaGene Inc , to 4,657,297, an increase of 17.61% since 01/29/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Here’s Why TrovaGene (TROV) Stock is Soaring Today

Here’s Why TrovaGene (TROV) Stock is Soaring Today

TrovaGene (TROV) stock is spiking on Monday afternoon as the company enters an agreement with FedMed for access to cancer monitoring tests and services.

TrovaGene (TROV) Is Weak On High Volume Today

TrovaGene (TROV) Is Weak On High Volume Today

Trade-Ideas LLC identified TrovaGene (TROV) as a weak on high relative volume candidate

Trovagene (TROV) Stock Soars on America's Choice Provider Network Partnership

Trovagene (TROV) Stock Soars on America's Choice Provider Network Partnership

Trovagene (TROV) stock is climbing on heavy trading volume on Thursday after the company announced a partnership with America's Choice Provider Network.

Oversold Conditions For TrovaGene (TROV)

Oversold Conditions For TrovaGene (TROV)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

TROV: Insiders vs. Shorts

TROV: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 11/30/2015 settlement date, and TrovaGene Inc is one of the most shorted stocks of the Russell 3000, based on 8.86 "days to cover" versus the median component at 6.38. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Interesting TROV Put And Call Options For July 2016

Interesting TROV Put And Call Options For July 2016

Investors in TrovaGene Inc saw new options begin trading this week, for the July 2016 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 233 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week of TROV December 18th Options Trading

First Week of TROV December 18th Options Trading

Investors in TrovaGene Inc saw new options become available this week, for the December 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TROV options chain for the new December 18th contracts and identified the following call contract of particular interest.

First Week Of April 2016 Options Trading For TrovaGene (TROV)

First Week Of April 2016 Options Trading For TrovaGene (TROV)

Investors in TrovaGene Inc saw new options begin trading this week, for the April 2016 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 231 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Oversold Conditions For TrovaGene (TROV)

Oversold Conditions For TrovaGene (TROV)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

TrovaGene Enters Oversold Territory (TROV)

TrovaGene Enters Oversold Territory (TROV)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Short Interest Expands By 99.5% For TROV

Short Interest Expands By 99.5% For TROV

The most recent short interest data has been released by the NASDAQ for the 07/15/2015 settlement date, which shows a 1,287,376 share increase in total short interest for TrovaGene Inc , to 2,581,460, an increase of 99.48% since 06/30/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

5 Health Care Stocks Under $10 Set to Soar

5 Health Care Stocks Under $10 Set to Soar

These under-$10 stocks look ready to break out and trade higher from current levels.

TrovaGene (TROV) Stock Tanks After Pricing Secondary Offering

TrovaGene (TROV) Stock Tanks After Pricing Secondary Offering

TrovaGene (TROV) shares are down after the company priced its secondary offering of 4 million shares.

TrovaGene (TROV) Highlighted As Weak On High Volume

TrovaGene (TROV) Highlighted As Weak On High Volume

Trade-Ideas LLC identified TrovaGene (TROV) as a weak on high relative volume candidate

Oversold Conditions For TrovaGene (TROV)

Oversold Conditions For TrovaGene (TROV)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

TrovaGene (TROV) Is Weak On High Volume Today

TrovaGene (TROV) Is Weak On High Volume Today

Trade-Ideas LLC identified TrovaGene (TROV) as a weak on high relative volume candidate

TrovaGene (TROV) Is Weak On High Volume Today

TrovaGene (TROV) Is Weak On High Volume Today

Trade-Ideas LLC identified TrovaGene (TROV) as a weak on high relative volume candidate

'Mad Money' Lightning Round: Caterpillar Is Troubled

'Mad Money' Lightning Round: Caterpillar Is Troubled

Cramer prefers SunEdisoin to SolarEdge Technologies and is urging caution on Chesapeake Energy.

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Cramer will be watching earnings from Sears, Lululemon and Cisco, among others, next week.

Trade-Ideas: TrovaGene (TROV) Is Today's Weak On High Relative Volume Stock

Trade-Ideas: TrovaGene (TROV) Is Today's Weak On High Relative Volume Stock

Trade-Ideas LLC identified TrovaGene (TROV) as a weak on high relative volume candidate